AERTS OSTEO THERAPY
ActiveSummary
The annual accounts of AERTS OSTEO THERAPY for financial year 2025 show a net loss of 77% of the equity at the start of that year. The 2025 annual accounts show equity of €2,459 and a net result of -€8,288. Equity has been growing by about 27% per year since 2021. Its solvency ranks better than 14% of 20,700 sector peers (NACE 86, financial year 2025). The company has been active since 2020 and the Belgian Official Gazette contains no insolvency or warning signals. The computed 12-month bankruptcy probability is 0.5% (low).
Overview
Official details
Source: KBO- Status
- Active since 11-06-2020 Normal situation
- Registered office
- 19 active companies are registered at this address 1 started in the 12 months before. Source: KBO register, as of 2 November 2026.
- Activity
- Human health activities NACE 86963
- Establishment unit
- 2.303.588.959 1180 Ukkel, since 11-06-2020
- Financial year end
- 30 June
- Peppol
- Not found in the Peppol Directory
Financial position
- Bankruptcy probabilitywithin 12 months
- 0.5%
- Gross margin
- €34,285
- ▼ 2.6%
- Turnover
- ≈ €100,000
- estimated
- Loss
- €8,288
- Equity
- €2,459
- ▼ 77.1%
- Total assets
- €23,619
- ▼ 52.1%
- Staff
- ≈ 0.7 FTE
- estimated
Score breakdownraises riskCapped at 59: a net loss of at least half of total assets or of the equity at the start of the financial yearLiquidity: current ratio 0.14Loss of €8,288 (financial year 2025)lowers riskSector: Human health activities (NACE 86)Size: total assets €23,619Show the evidence
Checked score
About 5 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
Calculation
The band follows from the bankruptcy probability. 10 more points roughly halve it.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro). It does better than 14% of them on solvency, 1% on liquidity, 5% on profitability and 8% on growth.
The bankruptcy probability was computed on 02-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
The company filed its last 5 accounts on average 4 days before the deadline. In the sector (NACE 86), the median for financial year 2024 was 7 days before the deadline, and 36% of those companies filed late.
Searched, nothing found (2)
Key points
- Caution: Lower net result than 95% of companies in human healthsector median €60,156 · 20,687 companies -€8,288 View
Recent changes
- · Gazette deed Incorporation
Comparable companies
These companies have their main activity in the same NACE class as AERTS OSTEO THERAPY: human health activities (NACE 8696). With exactly the same main activity (NACE 86963), too few companies are of comparable size. They are comparable in size and age: total assets between €26,300 and €49,500, founded between 2020 and 2025.
| Company | Total assets | Gross margin |
|---|---|---|
| AERTS OSTEO THERAPY Ukkel | €23,619 | €34,285 |
| Alissa Picchioni Kortrijk | €31,294 | €42,103 |
| Kine van Stokkum Eline Antwerpen | €29,561 | €24,810 |
| KERNPUNT Mechelen | €26,298 | €15,137 |
| PRAKTIJK STIEVEN GALLE Zulte | €44,083 | €45,933 |
| OSTEO BOSC Sint-Gillis (bij-Brussel) | €49,217 | €21,797 |
| PHYSIO PLUS Schaarbeek | €49,509 | €45,707 |
Key facts about AERTS OSTEO THERAPY
- What is the company number of AERTS OSTEO THERAPY?
- The company number of AERTS OSTEO THERAPY is 0748.454.275. The VAT number is the same number with BE in front: BE 0748.454.275.
- Where is AERTS OSTEO THERAPY based?
- The registered office is at Winston Churchilllaan 84, 1180 Ukkel.Company details
- What does AERTS OSTEO THERAPY do?
- According to the KBO register, the main activity is human health activities (NACE 86963).
- What is the legal form of AERTS OSTEO THERAPY?
- The legal form of AERTS OSTEO THERAPY is Private limited company (BV).
- When was AERTS OSTEO THERAPY founded?
- AERTS OSTEO THERAPY was founded on 11-06-2020.
- Is AERTS OSTEO THERAPY still active?
- Yes, AERTS OSTEO THERAPY is an active enterprise in the KBO register.
- How many employees does AERTS OSTEO THERAPY have?
- AERTS OSTEO THERAPY had an average of 0.7 full-time equivalents in financial year 2023, according to the filed annual accounts.Financials
- What is the turnover of AERTS OSTEO THERAPY?
- The turnover in financial year 2025 is ≈ €100,000. This figure is estimated from the gross margin of €34,285 and 34 comparable companies (NACE 869). It probably lies between €79,000 and €150,000.
- Is AERTS OSTEO THERAPY profitable?
- In financial year 2025, AERTS OSTEO THERAPY made a loss of €8,288.
- Where can I find the annual accounts of AERTS OSTEO THERAPY?
- AERTS OSTEO THERAPY filed 5 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of AERTS OSTEO THERAPY due?
- AERTS OSTEO THERAPY must file the annual accounts for financial year 2026 by 31-01-2027.Timeline
Next steps
See how customers, suppliers and banks see your own company and what to improve first.